HomeNews

News

News

First Sufferers Dosed in WU-CART-007 Trial for Blood Most cancers Subtypes

Editor -
The primary sufferers have been dosed in a trial of CAR T remedy in relapsed/refractory leukemia or lymphoma: © nobeatsoffierce - inventory.adobe.comThe primary...
News

Padcev With or With out Keytruda Elicits Responses in Urothelial Most cancers

Editor -
Padcev plus Keytruda elicited responses within the first-line setting, with Padcev exhibiting profit in later strains, in metastatic urothelial carcinoma: © freshidea -...
News

Colorectal Most cancers: Early Indicators, Dangers, and the Energy of Well timed Detection

Editor -
Colorectal most cancers usually begins silently, however sure warning indicators shouldn't be ignored. Signs embody modifications in bowel habits, blood in stool, unexplained...
News

FDA Grants Quick Observe Designation for Azer-Cel in Lymphoma Subset

Editor -
FDA grants quick monitor designation to azer-cel in relapsed/refractory DLBCL: © inventory.adobe.comThe U.S. Meals and Drug Administration (FDA) has granted quick monitor designation...
News

First Patent Dosed With Pocenbrodib in Trial for Metastatic Prostate Most cancers

Editor -
Pathos AI initiates a part 1b/2a trial evaluating pocenbrodib for metastatic prostate most cancers, testing it alone or with Zytiga, Lynparza or Pluvicto.The...
1...400401402...672Page 401 of 672

Hot Topics

Load more

Quick Links

Must Read

Popular Articles

© 2024 Cancer Care Portal. All rights reserved.